Asabys-backed Oriva Therapeutics appointed Dr Agnès Arbat as CEO to advance its clinical-stage women's health pipeline.
Oriva Therapeutics is a clinical-stage women’s health biotechnology company focused on the development of first-in-class and best-in-class therapies for chronic, prevalent gynecological diseases with high unmet medical need
Oriva Therapeutics is a clinical-stage women’s health biotechnology company focused on the development of first-in-class and best-in-class therapies for chronic, prevalent gynecological diseases with high unmet medical need.